Renaissance Capital logo

Omega Therapeutics Priced, Nasdaq: OMGA

Preclinical biotech developing gene therapies for oncology and other diseases.

Industry: Health Care

Latest Trade: $14.43 0.00 (0.0%)

First Day Return: -5.9%

Return from IPO: -15.1%

Industry: Health Care

At Omega Therapeutics, our goal is to pioneer a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to fundamentally transform human medicine in the service of patients. Our pioneering OMEGA Epigenomic Programming platform is designed to coopt nature’s universal operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. We have deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains, or IGDs. IGDs are the fundamental structural and functional units of gene control and cell differentiation and act as the “control room” of biology. Most diseases are caused by aberrant gene expression rooted in alterations in IGDs. The OMEGA platform has enabled us to systematically identify and validate thousands of novel DNA-sequence-based epigenomic “zip codes” within IGDs. We call these epigenomic targets EpiZips. We rationally design and engineer modular, programmable mRNA-encoded epigenetic medicines, which we call Omega Epigenomic Controllers, or OECs, to target EpiZips for Precision Genomic Control. This enables us to precisely tune genes to a desired level of expression and to control the duration of expression. Through this approach, we believe that the OMEGA platform has broad potential applicability across a range of diseases and conditions.
more less
IPO News for Omega Therapeutics
more
IPO Data
IPO File Date 07/09/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 7.4
Deal Size ($mm) $126
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/29/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 7.4
Deal Size ($mm) $126
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Cambridge, MA
Founded 2016
Employees 60
Website omegatherapeutics.com